US Patent Issued to UNIVERSITY OF SOUTH CAROLINA on Sept. 30 for "Carrier-free curcumin nanoparticles for EGFR-positive cancer therapy" (South Carolina Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,198, issued on Sept. 30, was assigned to UNIVERSITY OF SOUTH CAROLINA (Columbia, S.C.).

"Carrier-free curcumin nanoparticles for EGFR-positive cancer therapy" was invented by Peisheng Xu (Columbia, S.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A carrier-free nanoparticle based on the self-assembly of curcumin-erlotinib conjugate (EPC) that exhibits stronger cell killing, better anti-migration effects, and anti-invasion effects for pancreatic cancer cells than the combination of free curcumin and erlotinib."

The patent was filed on Jan. 10, 2024, under Application No. 18/409,042.

*For further information, including images, charts and tables,...